MYC plays, instead, a crucial role in the development and progression of ARMS, a highly aggressive pediatric cancer characterized by its association with specific fusion proteins, primarily PAX3-FOXO1 or PAX7-FOXO1 [31]. This evidence concerns the gene MYC and alveolar rhabdomyosarcoma.